title: Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats.
abstract: Leucine aminopeptidase M significantly reduced blood pressure for up to 40 minutes when infused intracerebroventricularly into anesthetized spontaneously hypertensive rats (SHR) from a mean +/- SEM of 190 +/- 4 to 94 +/- 7 mm Hg and also in normotensive Wistar-Kyoto (WKY) rats from 138 +/- 5 to 68 +/- 8 mm Hg. Cerebrospinal fluid levels of angiotensin II (Ang II) and III were measured by radioimmunoassay and indicated drops with leucine aminopeptidase M infusion in SHR (from 36 +/- 6 to 11 +/- 1 pg/100 microliters) and in WKY rats (from 33 +/- 9 to 13 +/- 1 pg/100 microliters). Pretreatment with the specific angiotensin receptor antagonist [Sar1, Thr8]Ang II (sarthran) significantly diminished the subsequent leucine aminopeptidase M-induced decreases in blood pressure in SHR and facilitated recovery to base level blood pressure and heart rate in blood strains. Thus, exogenous application of leucine aminopeptidase M into the brain lateral ventricles of SHR is temporarily effective at reducing blood pressure, and this effect appears dependent on the brain angiotensinergic system. This treatment also reduced blood pressure in WKY rats; however, pretreatment with sarthran was reasonably ineffective at preventing subsequent leucine aminopeptidase M-induced decreases in blood pressure.
authors.affiliation: Department of Psychology, Washington State University, Pullman 99164-4830.
authors.forename: J W
authors.initials: JW
authors.lastname: Wright
authors.forename: L L
authors.initials: LL
authors.lastname: Jensen
authors.forename: L L
authors.initials: LL
authors.lastname: Cushing
authors.forename: J W
authors.initials: JW
authors.lastname: Harding
mesh_terms: D000804:Angiotensin II / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000134:cerebrospinal fluid / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002552:Cerebral Ventricles / Q000502:physiology; D006973:Hypertension / Q000378:metabolism / Q000503:physiopathology*; D007276:Injections, Intraventricular; D007931:Leucyl Aminopeptidase / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY
chemical_list: D000804:Angiotensin II; C014805:angiotensin II, Sar(1)-Thr(8)-; D007931:Leucyl Aminopeptidase